Specialty Enzymes Market by Type (Carbohydrases, Proteases, Lipases, Polymerases & Nucleases, and Other enzymes), Source, Application (pharmaceuticals, Research & Biotechnology, Diagnostics, and Biocatalysts), Form, and Region - Global Forecast to 2025

特殊酵素の世界市場予測:種類別(カルボヒドラーゼ、プロテアーゼ、リパーゼ、ポリメラーゼ&ヌクレアーゼ、その他)、ソース別、用途別(医薬品、研究&バイオテクノロジー、診断、生体触媒)、形態別、地域別

◆タイトル:Specialty Enzymes Market by Type (Carbohydrases, Proteases, Lipases, Polymerases & Nucleases, and Other enzymes), Source, Application (pharmaceuticals, Research & Biotechnology, Diagnostics, and Biocatalysts), Form, and Region - Global Forecast to 2025
◆商品コード:FB 2276
◆調査・発行会社:MarketsandMarkets
◆発行日:2020年4月30日
◆ページ数:181
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:食品&飲料
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥519,750見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥698,250見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥855,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社は特殊酵素の世界市場が、2019年44億ドルから2025年66億ドルまで、年平均6.9%成長すると予測しています。本調査レポートでは、特殊酵素の世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場動向、特許分析、種類別(カルボヒドラーゼ、プロテアーゼ、リパーゼ、ポリメラーゼ&ヌクレアーゼ、その他)分析、用途別(医薬品、研究&バイオテクノロジー、診断、生体触媒)分析、ソース別(微生物、植物、動物)分析、形態別(液体、乾燥)分析、地域別分析、競争状況、企業概要などを含め、今後の方向性を提示しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場動向
・特許分析
・特殊酵素の世界市場:種類別(カルボヒドラーゼ、プロテアーゼ、リパーゼ、ポリメラーゼ&ヌクレアーゼ、その他)
・特殊酵素の世界市場:用途別(医薬品、研究&バイオテクノロジー、診断、生体触媒)
・特殊酵素の世界市場:ソース別(微生物、植物、動物)
・特殊酵素の世界市場:形態別(液体、乾燥)
・特殊酵素の世界市場:地域別
・競争状況
・企業概要

“The specialty enzymesmarket isprojected to grow at a CAGR of6.9% during the forecast period.”
According to MarketsandMarkets, the specialty enzymes market is estimated to be valued atUSD 4.4 billion in 2019 and is projected to reach USD 6.6billion by 2025, recording a CAGR of 6.9% in terms of value. Factors such as the rise in demand for non-harmful biological catalysts in pharmaceuticals & diagnosticsandadvanced tools to optimize pharmaceutical productionare projected to drive the growth of the specialty enzymes market during the forecast period. However, the growth of the specialty enzymesmarket is inhibited by factors, such as high adaption costs involved for small &medium-sized enterprises. In addition, the lack of harmonization in the regulatory framework for the use of specialty enzymes inhibits the growth of this market.

“By type, the proteasessegmentis projected to grow at thehighest CAGR of 7.4% during the forecast period.”
The proteases segment is projected to reach USD 871.2 million by 2025, recording a CAGR of 7.4% in terms of value. Proteases are enzymes essential for the digestion of protein and have become significant for use in the pharmaceutical industry. They can hydrolyze all types of proteins, provided that they are not components of living cells.These enzymes can be obtained from plants, animals, and microorganisms in several conditions, such as high salt concentrations.

“By source, the microorganismssegment is estimated to account for the largest share.”
Based on source, the specialty enzymes market is segmented intomicroorganisms, plants, and animals.The microorganismssegment is estimated to account for the largest share for the specialty enzymes market,as they are the primary source of specialty enzymes due to its special characteristics and other biochemical properties.In addition, microbial enzymes are an important source of raw materials for specialty applications due totheir diversity.Key factors that encourage manufacturersto opt for enzymes from microbial sources are their active and stable nature and their capability to degrade a wide range of complex substrates into more useful energy sources.

“By region, the Asia Pacific regionis projected to grow at thehighest CAGR of 8.0% during the forecast period.”
The specialty enzymes market in the Asia Pacificregion is largely driven by industrial shift and technological advancements that have made enzymes available for a wide range of applications.Developed markets such as North America and Western Europe are becoming mature, which has led to faster growth in developing markets such as Asia Pacific. Furthermore, the technological advancements in the pharmaceutical industry havecontributednotably to the growth of the specialty enzymes market in this region.

The specialty enzymesmarketis segmented region-wise, with a detailed analysis of each region. These regions include North America, Europe, AsiaPacific,and RoW (Brazil, Argentina, South Africa, and RoW).

Break-up of Primaries
 By Value Chain:Supply-side – 57% and Demand-side – 43%
 By Designation:CXOs – 29%,Managers–21%, and Executives–50%
 By Region:North America – 34%, Europe – 37%,Asia Pacific – 16%,and RoW – 13%

Leading players profiled in this report include the following:
• BASF (Germany)
• Novozymes (Denmark)
• Roche Holding (Switzerland)
• DuPont (US)
• Codexis (US)
• Dyadic International (US)
• Advanced Enzymes (India)
• Amano Enzymes (Japan)
• Sanofi (France)
• Biocatalysts (UK)
• Enzyme Supplies (UK)
• BBI Solutions (UK)
• Specialty Enzymes & Probiotics (US)
• Amicogen (South Korea)
• Antozyme Biotech (India)
• Enzyme Development Corporation (US)
• Nagase & Co. Ltd. (Japan)
• Sekisui Diagnostics (US)
• Merck (Germany)
• Biovet (Bulgaria)

Research Coverage
This report segmentsthespecialty enzymesmarket on the basis oftype, source,form, application, and region. In terms of insights, this research report focuses on various levels of analyses—competitive landscape,pricing insights, end-use analysis, and company profiles—which together comprise and discuss the basic views on the emerging & high-growth segments of the specialty enzymesmarket, high-growth regions, countries, industry trends, drivers, restraints, opportunities, and challenges.

Reasons to buy this report
• To get a comprehensive overview of the specialty enzymesmarket
• To gain wide-ranging information about the top players in this industry, their product portfolio details, and the key strategies adopted by them
• To gain insights about the major countries/regions, in which the specialty enzymesmarket is flourishing

【レポートの目次】

1 INTRODUCTION (Page No. – 19)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 REGIONS COVERED
1.3.2 PERIODIZATION CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 VOLUME UNIT CONSIDERED
1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. – 24)
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key Data from Secondary Sources
2.1.2 PRIMARY DATA
2.1.2.1 Key Data from Primary Sources
2.2 FACTOR ANALYSIS
2.2.1 INTRODUCTION
2.2.2 DEMAND-SIDE ANALYSIS
2.2.3 SUPPLY-SIDE ANALYSIS
2.3 MARKET SIZE ESTIMATION
2.3.1 APPROACH ONE (BASED ON APPLICATION, BY REGION)
2.3.2 APPROACH TWO (BASED ON THE GLOBAL MARKET)
2.4 DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY (Page No. – 37)

4 PREMIUM INSIGHTS (Page No. – 42)
4.1 ATTRACTIVE OPPORTUNITIES IN THE SPECIALTY ENZYMES MARKET
4.2 SPECIALTY ENZYMES MARKET: MAJOR REGIONAL SUBMARKETS
4.3 NORTH AMERICA: SPECIALTY ENZYMES MARKET, BY APPLICATION AND KEY COUNTRY
4.4 MARKET, BY TYPE AND REGION
4.5 MARKET, BY APPLICATION

5 MARKET OVERVIEW (Page No. – 47)
5.1 INTRODUCTION
5.2 YC-YCC SHIFT
5.3 ROLE OF SPECIALTY ENZYMES IN COMBATING THE COVID-19 (CORONAVIRUS) PANDEMIC
5.3.1 BROAD-SPECTRUM ANTIVIRAL ADVANCEMENTS TO COMBAT CORONAVIRUS
5.3.1.1 ADP-ribosylation-based developments could be a potential vaccine component
5.3.1.2 Real-time reverse-transcription-polymerases chain reaction assay for COVID-19 has been developed and used in clinics
5.4 VALUE CHAIN
5.5 MARKET DYNAMICS
5.5.1 DRIVERS
5.5.1.1 Rise in Demand for Non-harmful Biological Catalysts in Pharmaceuticals & Diagnostics
5.5.1.2 Advanced Tools to Optimize Pharmaceutical Production
5.5.2 RESTRAINTS
5.5.2.1 Lack of Harmonization in the Regulatory Framework
5.5.2.2 High Adoption Costs involved for Small & Medium Enterprises
5.5.3 OPPORTUNITIES
5.5.3.1 Alternative to Chemical Catalysts
5.5.3.2 Technological Innovations and Wide Industry Scope
5.5.3.3 Launching Enzymes with Long Shelf life
5.5.3.3.1 Encapsulation to enhance shelf life
5.5.4 CHALLENGES
5.5.4.1 High Raw Material Costs Limiting Enzyme Usage
5.5.4.2 Concern Over Quality of Enzymes Used in Pharmaceuticals & Diagnostics

6 PATENT ANALYSIS (Page No. – 57)
6.1 INTRODUCTION

7 SPECIALTY ENZYMES MARKET, BY TYPE (Page No. – 62)
7.1 INTRODUCTION
7.2 CARBOHYDRASES
7.2.1 AMYLASES
7.2.2 CELLULASES
7.2.3 OTHER CARBOHYDRASES
7.3 PROTEASES
7.3.1 COMPETENT CHARACTERISTIC TO HYDROLYZE THE PROTEINS IS USED IN DIAGNOSTICS TO REVERSE THE PROGRESSION OF THE DISEASE
7.4 LIPASES
7.4.1 RISE IN DEMAND AMONG PHARMACEUTICAL MANUFACTURERS AS LIPASES ADMINISTRATE ENZYME DEFICIENCIES IN HUMANS
7.5 POLYMERASES & NUCLEASES
7.5.1 POLYMERASES & NUCLEASES FORM AN ESSENTIAL PART FOR ALL NUCLEIC ACID PROCESSES
7.6 OTHER ENZYMES
7.6.1 FUNCTIONAL BENEFITS IN VARIOUS APPLICATIONS HAVE BEEN DRIVING THE MARKET FOR OTHER ENZYMES

8 SPECIALTY ENZYMES MARKET, BY APPLICATION (Page No. – 73)
8.1 INTRODUCTION
8.2 PHARMACEUTICALS
8.2.1 ENZYMES ACT AS AN ALTERNATIVE TO TRADITIONAL ANTIBIOTICS
8.3 RESEARCH & BIOTECHNOLOGY
8.3.1 USE OF ENZYMES IN DNA SEQUENCING REDUCES THE COST FOR SEQUENCING TECHNIQUES
8.4 DIAGNOSTICS
8.4.1 DIAGNOSING LIFE-THREATENING DISEASES AT AN INITIAL STAGE DRIVES THE DEMAND FOR SPECIALTY ENZYMES
8.5 BIOCATALYSTS
8.5.1 BIOCATALYSIS IS A PROMISING TECHNOLOGY IN WASTE MATERIAL TREATMENT

9 SPECIALTY ENZYMES MARKET, BY SOURCE (Page No. – 81)
9.1 INTRODUCTION
9.2 MICROORGANISMS
9.2.1 HUGE PRODUCTION IN LESSER TIME BOOSTS THE INDUSTRIAL USAGE OF MICROBIAL ENZYMES
9.3 PLANTS
9.3.1 PLANT-BASED ENZYMES THRIVE OVER A WIDE RANGE OF TEMPERATURES
9.4 ANIMALS
9.4.1 BEING TEMPERATURE-SENSITIVE DISCOURAGES THE INDUSTRIAL USAGE OF ANIMAL-BASED ENZYMES

10 SPECIALTY ENZYMES MARKET, BY FORM (Page No. – 86)
10.1 INTRODUCTION
10.2 LIQUID
10.2.1 EASE OF USE IN THE DIAGNOSTIC INDUSTRY BOOSTS THE USAGE OF THE LIQUID FORM
10.3 DRY
10.3.1 DRY FORM ENABLES A BETTER ACCURACY OF DOSAGES

11 SPECIALTY ENZYMES MARKET, BY REGION (Page No. – 88)
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 US
11.2.1.1 Increasing awareness among manufacturers pertaining to the enhanced product quality with the usage of enzymes to drive the market growth in the US
11.2.2 CANADA
11.2.2.1 Enzymes usage has witnessed an increase in demand in cancer diagnosis
11.2.3 MEXICO
11.2.3.1 Enzymes can be used in diagnostics to detect the changes in the substrate concentrations
11.3 EUROPE
11.3.1 ITALY
11.3.1.1 Rise in production in the pharmaceutical industry could increase the demand for specialty enzymes
11.3.2 GERMANY
11.3.2.1 Rise in research & development involved in the pharmaceutical industry drives the demand for enzymes
11.3.3 FRANCE
11.3.3.1 Rise in clinical developments would impact the French biotechnology industry and increase the usage of specialty enzymes
11.3.4 SPAIN
11.3.4.1 Spanish government’s emphasis on developments in the pharmaceutical industry resulting in boosting the enzymes market
11.3.5 UK
11.3.5.1 Enzymes used in the drug cloning technique could boost the market for specialty enzymes
11.3.6 REST OF EUROPE
11.3.6.1 Growth in the pharmaceutical industry in most European countries driving the specialty enzymes market
11.4 ASIA PACIFIC
11.4.1 CHINA
11.4.1.1 Technical advancements augmenting the demand for specialty enzymes in China
11.4.2 INDIA
11.4.2.1 The rising demand in the pharmaceutical industry would boost the specialty enzymes market
11.4.3 JAPAN
11.4.3.1 Growing biotechnology advancements in Japan would augment the demand for specialty enzymes
11.4.4 AUSTRALIA & NEW ZEALAND
11.4.4.1 Favorable government regulations would increase biotechnology advancements, which would result in the rise in specialty enzymes usage
11.4.5 REST OF ASIA PACIFIC
11.4.5.1 Developing countries in the Asia Pacific region present immense scope for the enzymes industry
11.5 REST OF THE WORLD
11.5.1 BRAZIL
11.5.1.1 The emerging pharmaceutical industry in Brazil driving the demand for enzymes
11.5.2 ARGENTINA
11.5.2.1 Technological pharmaceutical advancements would boost the market for enzymes
11.5.3 SOUTH AFRICA
11.5.3.1 Rising demand for generic medicines boosts growth in the South African pharmaceutical industry
11.5.4 OTHERS IN ROW
11.5.4.1 Biotechnological advancements in African nations drive the market for specialty enzymes

12 COMPETITIVE LANDSCAPE (Page No. – 127)
12.1 INTRODUCTION
12.2 COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET)
12.2.1 VISIONARY LEADERS
12.2.2 DYNAMIC DIFFERENTIATORS
12.2.3 INNOVATORS
12.2.4 EMERGING COMPANIES
12.3 RANKING OF KEY PLAYERS, 2018
12.4 STRENGTH OF PRODUCT PORTFOLIO (OVERALL MARKET)
12.5 BUSINESS STRATEGY EXCELLENCE (OVERALL MARKET)
12.6 COMPETITIVE SCENARIO
12.6.1 EXPANSIONS & INVESTMENTS
12.6.2 AGREEMENTS, COLLABORATIONS, AND JOINT VENTURES
12.6.3 NEW PRODUCT LAUNCHES
12.6.4 ACQUISITIONS
12.7 COMPETITIVE LEADERSHIP MAPPING (START-UP/SME)
12.7.1 PROGRESSIVE COMPANIES
12.7.2 STARTING BLOCKS
12.7.3 RESPONSIVE COMPANIES
12.7.4 DYNAMIC COMPANIES
12.8 STRENGTH OF PRODUCT PORTFOLIO (STARTUP/SME)
12.9 BUSINESS STRATEGY EXCELLENCE (STARTUP/SME)

13 COMPANY PROFILES (Page No. – 139)
(Business overview, Products offered, Recent Developments, SWOT analysis, MNM view)*
13.1 BASF
13.2 NOVOZYMES
13.3 ROCHE HOLDING
13.4 DUPONT
13.5 CODEXIS
13.6 DYADIC INTERNATIONAL
13.7 ADVANCED ENZYMES
13.8 AMANO ENZYME
13.9 SANOFI
13.10 BIOCATALYSTS
13.11 ENZYME SUPPLIES
13.12 BBI SOLUTIONS
13.13 SPECIALTY ENZYMES & PROBIOTICS
13.14 AMICOGEN
13.15 ANTOZYME BIOTECH
13.16 ENZYME DEVELOPMENT CORPORATION
13.17 NAGASE & CO. LTD.
13.18 SEKISUI DIAGNOSTICS
13.19 MERCK KGAA
13.20 BIOVET
*Details on Business overview, Products offered, Recent Developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.

14 APPENDIX (Page No. – 172)
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 AVAILABLE CUSTOMIZATIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS

LIST OF TABLES (110 Tables)

TABLE 1 USD EXCHANGE RATES CONSIDERED, 2014–2019
TABLE 2 SPECIALTY ENZYMES MARKET SNAPSHOT, 2019 VS. 2025
TABLE 3 PATENTS PERTAINING TO ENZYMES, 2017–2020
TABLE 4 SPECIALTY ENZYMES MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 5 SPECIALTY ENZYMES MARKET SIZE, BY TYPE, 2017–2025 (TON)
TABLE 6 CARBOHYDRASES MARKET SIZE, BY REGION, 2017–2025 (USD MILLION)
TABLE 7 CARBOHYDRASES MARKET SIZE, BY SUBTYPE, 2017–2025 (USD MILLION)
TABLE 8 CARBOHYDRASES MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 9 AMYLASES MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 10 CELLULASES MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 11 OTHER CARBOHYDRASES MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 12 PROTEASES MARKET SIZE, BY REGION, 2017–2025 (USD MILLION)
TABLE 13 PROTEASES MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 14 LIPASES MARKET SIZE, BY REGION, 2017–2025 (USD MILLION)
TABLE 15 LIPASES MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 16 POLYMERASES & NUCLEASES MARKET SIZE, BY REGION, 2017–2025 (USD MILLION)
TABLE 17 POLYMERASES & NUCLEASES MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 18 OTHER ENZYMES MARKET SIZE, BY REGION, 2017–2025 (USD MILLION)
TABLE 19 OTHER ENZYMES MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 20 MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 21 MARKET SIZE IN PHARMACEUTICALS, BY REGION, 2017–2025 (USD MILLION)
TABLE 22 MARKET SIZE IN PHARMACEUTICALS, BY TYPE, 2017–2025 (USD MILLION)
TABLE 23 MARKET SIZE IN RESEARCH & BIOTECHNOLOGY, BY REGION, 2017–2025 (USD MILLION)
TABLE 24 SPECIALTY ENZYMES MARKET SIZE IN RESEARCH & BIOTECHNOLOGY, BY TYPE, 2017–2025 (USD MILLION)
TABLE 25 SPECIALTY ENZYMES MARKET SIZE IN DIAGNOSTICS, BY REGION, 2017–2025 (USD MILLION)
TABLE 26 MARKET SIZE IN DIAGNOSTICS, BY TYPE, 2017–2025 (USD MILLION)
TABLE 27 MARKET SIZE IN BIOCATALYSTS, BY REGION, 2017–2025 (USD MILLION)
TABLE 28 MARKET SIZE IN BIOCATALYSTS, BY TYPE, 2017–2025 (USD MILLION)
TABLE 29 MARKET SIZE, BY SOURCE, 2017–2025 (USD MILLION)
TABLE 30 MICROORGANISM-BASED MARKET SIZE, BY REGION, 2017–2025 (USD MILLION)
TABLE 31 PLANT-BASED MARKET SIZE, BY REGION, 2017–2025 (USD MILLION)
TABLE 32 ANIMAL-BASED MARKET SIZE, BY REGION, 2017–2025 (USD MILLION)
TABLE 33 SPECIALTY ENZYMES MARKET SIZE, BY REGION, 2017–2025 (USD MILLION)
TABLE 34 NORTH AMERICA: MARKET SIZE, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 35 NORTH AMERICA: MARKET SIZE FOR PHARMACEUTICALS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 36 NORTH AMERICA: MARKET SIZE FOR RESEARCH & BIOTECHNOLOGY, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 37 NORTH AMERICA: MARKET SIZE FOR DIAGNOSTICS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 38 NORTH AMERICA: MARKET SIZE FOR BIOCATALYSTS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 39 NORTH AMERICA: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 40 NORTH AMERICA: MARKET SIZE, BY TYPE, 2017–2025 (TON)
TABLE 41 NORTH AMERICA: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 42 NORTH AMERICA: ENZYMES MARKET SIZE, BY SOURCE, 2017–2025 (USD MILLION)
TABLE 43 US: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 44 US: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 45 CANADA: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 46 CANADA: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 47 CANADA: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 48 MEXICO: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 49 MEXICO: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 50 EUROPE: MARKET SIZE, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 51 EUROPE: MARKET SIZE FOR PHARMACEUTICALS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 52 EUROPE: MARKET SIZE FOR RESEARCH & BIOTECHNOLOGY, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 53 EUROPE: SPECIALTY ENZYMES MARKET SIZE FOR DIAGNOSTICS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 54 EUROPE: SPECIALTY ENZYMES MARKET SIZE FOR BIOCATALYSTS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 55 EUROPE: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 56 EUROPE: MARKET SIZE, BY TYPE, 2017–2025 (TONS)
TABLE 57 EUROPE: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 58 EUROPE: ENZYMES MARKET SIZE, BY SOURCE, 2017–2025 (USD MILLION)
TABLE 59 ITALY: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 60 ITALY: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 61 GERMANY: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 62 GERMANY: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 63 FRANCE: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 64 FRANCE: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 65 SPAIN: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 66 SPAIN: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 67 UK: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 68 UK: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 69 REST OF EUROPE: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 70 REST OF EUROPE: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 71 ASIA PACIFIC: MARKET SIZE, BY COUNTRY/REGION, 2017–2025 (USD MILLION)
TABLE 72 ASIA PACIFIC: MARKET SIZE FOR PHARMACEUTICALS, BY COUNTRY/REGION, 2017–2025 (USD MILLION)
TABLE 73 ASIA PACIFIC: MARKET SIZE FOR RESEARCH & BIOTECHNOLOGY, BY COUNTRY/REGION, 2017–2025 (USD MILLION)
TABLE 74 ASIA PACIFIC: MARKET SIZE FOR DIAGNOSTICS, BY COUNTRY/REGION, 2017–2025 (USD MILLION)
TABLE 75 ASIA PACIFIC: MARKET SIZE FOR BIOCATALYSTS, BY COUNTRY/REGION, 2017–2025 (USD MILLION)
TABLE 76 ASIA PACIFIC: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 77 ASIA PACIFIC: MARKET SIZE, BY TYPE, 2017–2025 (TONS)
TABLE 78 ASIA PACIFIC: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 79 ASIA PACIFIC: ENZYMES MARKET SIZE, BY SOURCE, 2017–2025 (USD MILLION)
TABLE 80 CHINA: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 81 CHINA: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 82 INDIA: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 83 INDIA: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 84 JAPAN: SPECIALTY ENZYMES MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 85 JAPAN: SPECIALTY ENZYMES MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 86 AUSTRALIA & NEW ZEALAND: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 87 AUSTRALIA & NEW ZEALAND: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 88 REST OF ASIA PACIFIC: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 89 REST OF ASIA PACIFIC: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 90 ROW: MARKET SIZE, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 91 ROW: MARKET SIZE FOR PHARMACEUTICALS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 92 ROW: MARKET SIZE FOR RESEARCH & BIOTECHNOLOGY, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 93 ROW: MARKET SIZE FOR DIAGNOSTICS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 94 ROW: MARKET SIZE FOR BIOCATALYSTS, BY COUNTRY, 2017–2025 (USD MILLION)
TABLE 95 ROW: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 96 ROW: MARKET SIZE, BY TYPE, 2017–2025 (TON)
TABLE 97 ROW: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 98 ROW: ENZYMES MARKET SIZE, BY SOURCE, 2017–2025 (USD MILLION)
TABLE 99 BRAZIL: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 100 BRAZIL: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION) 123
TABLE 101 ARGENTINA: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 102 ARGENTINA: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 103 SOUTH AFRICA: MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 104 SOUTH AFRICA: MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 105 OTHERS IN ROW: SPECIALTY ENZYMES MARKET SIZE, BY APPLICATION, 2017–2025 (USD MILLION)
TABLE 106 OTHERS IN ROW: SPECIALTY ENZYMES MARKET SIZE, BY TYPE, 2017–2025 (USD MILLION)
TABLE 107 EXPANSIONS & INVESTMENTS, 2017–2019
TABLE 108 AGREEMENTS, COLLABORATIONS, AND JOINT VENTURES, 2017–2019
TABLE 109 NEW PRODUCT LAUNCHES, 2017–2019
TABLE 110 ACQUISITIONS, 2017–2019

LIST OF FIGURES (53 Figures)

FIGURE 1 MARKET SEGMENTATION
FIGURE 2 SPECIALTY ENZYMES MARKET: RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY VALUE CHAIN, DESIGNATION, AND REGION
FIGURE 4 GDP GROWTH OF KEY ECONOMIES, 2013–2018 (USD TRILLION)
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 SPECIALTY ENZYMES MARKET SIZE, BY TYPE, 2019 VS. 2025 (USD MILLION)
FIGURE 8 MARKET SIZE, BY TYPE, 2019 VS. 2025 (TON)
FIGURE 9 MARKET SIZE, BY APPLICATION, 2019 VS. 2025 (USD MILLION)
FIGURE 10 MARKET SIZE, BY SOURCE, 2019 VS. 2025 (USD MILLION)
FIGURE 11 MARKET SHARE (VALUE), BY REGION, 2018
FIGURE 12 GROWING DEMAND FOR PHARMACEUTICAL PRODUCTS IS PROJECTED TO DRIVE THE GROWTH OF THE MARKET
FIGURE 13 US WAS THE LARGEST MARKET GLOBALLY FOR SPECIALTY ENZYMES IN 2018
FIGURE 14 US ACCOUNTED FOR THE LARGEST SHARE IN THE NORTH AMERICAN MARKET IN 2018
FIGURE 15 NORTH AMERICA IS PROJECTED TO DOMINATE THE MARKET FOR SPECIALTY ENZYMES, 2019 VS. 2025
FIGURE 16 THE PHARMACEUTICALS SEGMENT IS PROJECTED TO DOMINATE THE MARKET DURING THE FORECAST PERIOD, 2019 VS. 2025
FIGURE 17 MARKET: VALUE CHAIN
FIGURE 18 MARKET DYNAMICS
FIGURE 19 FOOD DIAGNOSTICS MARKET SIZE, BY REGION, 2016–2023 (USD BILLION)
FIGURE 20 INDIA: REVENUE OF THE PHARMACEUTICAL SECTOR, 2016–2019 (USD BILLION)
FIGURE 21 GLOBAL EXPENDITURE ON R&D, 2015–2018 (USD MILLION)
FIGURE 22 PATENT INSIGHTS
FIGURE 23 SPECIALTY ENZYMES MARKET SHARE (VALUE), BY TYPE, 2019 VS. 2025
FIGURE 24 MARKET SHARE (VALUE), BY APPLICATION, 2019 VS. 2025
FIGURE 25 MARKET SHARE (VALUE), BY SOURCE, 2019 VS. 2025
FIGURE 26 FLOW CHART FOR THE PRODUCTION OF DRY ENZYMES
FIGURE 27 SPECIALTY ENZYMES MARKET GROWTH, BY KEY COUNTRY, 2019–2025
FIGURE 28 NORTH AMERICA: SPECIALTY ENZYMES MARKET SNAPSHOT
FIGURE 29 EUROPE: SPECIALTY ENZYMES MARKET SNAPSHOT, 2018
FIGURE 30 ASIA PACIFIC: SPECIALTY ENZYMES MARKET SNAPSHOT
FIGURE 31 SPECIALTY ENZYMES MARKET (OVERALL MARKET): COMPETITIVE LEADERSHIP MAPPING, 2018
FIGURE 32 BASF LED THE SPECIALTY ENZYMES MARKET IN 2018
FIGURE 33 PRODUCT PORTFOLIO ANALYSIS OF TOP PLAYERS IN (OVERALL MARKET) SPECIALTY ENZYMES MARKET
FIGURE 34 BUSINESS STRATEGY EXCELLENCE OF TOP PLAYERS IN (OVERALL MARKET) MARKET
FIGURE 35 SPECIALTY ENZYMES MARKET (START-UP/SME): COMPETITIVE LEADERSHIP MAPPING, 2018
FIGURE 36 PRODUCT PORTFOLIO ANALYSIS OF TOP PLAYERS IN (STARTUP/SME) SPECIALTY ENZYMES MARKET
FIGURE 37 BUSINESS STRATEGY EXCELLENCE OF TOP PLAYERS IN (STARTUP/SME) SPECIALTY ENZYMES MARKET
FIGURE 38 BASF: COMPANY SNAPSHOT
FIGURE 39 BASF: SWOT ANALYSIS
FIGURE 40 NOVOZYMES: COMPANY SNAPSHOT
FIGURE 41 NOVOZYMES: SWOT ANALYSIS
FIGURE 42 ROCHE HOLDING: COMPANY SNAPSHOT
FIGURE 43 ROCHE HOLDING: SWOT ANALYSIS
FIGURE 44 DUPONT: COMPANY SNAPSHOT
FIGURE 45 DUPONT: SWOT ANALYSIS
FIGURE 46 CODEXIS: COMPANY SNAPSHOT
FIGURE 47 CODEXIS: SWOT ANALYSIS
FIGURE 48 DYADIC INTERNATIONAL: COMPANY SNAPSHOT
FIGURE 49 ADVANCED ENZYMES: COMPANY SNAPSHOT
FIGURE 50 SANOFI: COMPANY SNAPSHOT
FIGURE 51 AMICOGEN: COMPANY SNAPSHOT
FIGURE 52 NAGASE & CO. LTD.: COMPANY SNAPSHOT
FIGURE 53 MERCK KGAA: COMPANY SNAPSHOT



★調査レポート[特殊酵素の世界市場予測:種類別(カルボヒドラーゼ、プロテアーゼ、リパーゼ、ポリメラーゼ&ヌクレアーゼ、その他)、ソース別、用途別(医薬品、研究&バイオテクノロジー、診断、生体触媒)、形態別、地域別] ( Specialty Enzymes Market by Type (Carbohydrases, Proteases, Lipases, Polymerases & Nucleases, and Other enzymes), Source, Application (pharmaceuticals, Research & Biotechnology, Diagnostics, and Biocatalysts), Form, and Region - Global Forecast to 2025 / FB 2276) 販売に関する免責事項
[特殊酵素の世界市場予測:種類別(カルボヒドラーゼ、プロテアーゼ、リパーゼ、ポリメラーゼ&ヌクレアーゼ、その他)、ソース別、用途別(医薬品、研究&バイオテクノロジー、診断、生体触媒)、形態別、地域別] ( Specialty Enzymes Market by Type (Carbohydrases, Proteases, Lipases, Polymerases & Nucleases, and Other enzymes), Source, Application (pharmaceuticals, Research & Biotechnology, Diagnostics, and Biocatalysts), Form, and Region - Global Forecast to 2025 / FB 2276) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆